Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 1/20 | 0.62 |
| ▸ | DNM1 | Q05193 | 15/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexadecylamine SCHEMBL28318344 | 1.00 | LSS (0.62) | LSSDNM1MEN1KMT2AALDH1A1 | |
| Decylamine SCHEMBL27936573 | 1.00 | LSS (0.62) | LSSDNM1MEN1KMT2AALDH1A1 | |
| Octadecylamine SCHEMBL23633143 | 1.00 | LSS (0.62) | LSSDNM1MEN1KMT2AALDH1A1 | |
| Decylamine SCHEMBL25283760 | 0.91 | LSS (0.77) | LSSDNM1MEN1KMT2AALDH1A1 | |
| Dectaflur SCHEMBL27903824 | 0.89 | LSS (0.50) | LSSDNM1MEN1KMT2AALDH1A1 | |
| Octane SCHEMBL29183971 | 0.88 | LSS (0.73) | LSSDNM1MEN1KMT2AALDH1A1 | |
| Tetramethylammonium Ion SCHEMBL28952238 | 0.80 | DNM1 (0.81) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Tetramethylammonium Ion SCHEMBL4626241 | 0.80 | DNM1 (0.81) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Tetradecylamine SCHEMBL11856044 | 0.80 | DNM1 (0.93) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Hydrogen Sulfide SCHEMBL28841896 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117503661-A | Preparation method of Rosa roxburghii extract and application of freeze-dried powder thereof in cosmetics | 珠海远大美业生物科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117503661-B | Preparation method of Rosa roxburghii extract and application of freeze-dried powder thereof in cosmetics | 珠海远大美业生物科技有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117503661-A | Preparation method of Rosa roxburghii extract and application of freeze-dried powder thereof in cosmetics | 珠海远大美业生物科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-109563449-A | Use of enzymes, compositions and methods for removing soils | 诺维信公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109477042-A | Purposes, cleaning compositions and the method for washing of enzyme | 诺维信公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-109153943-A | manganese bleach catalyst particles | 诺维信公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-107683326-A | Manganese bleach catalyst/enzyme particles for dishwashing detergents | 诺维信公司 | 2018-02-09 | — | — | CN | disclosed |
| CN-106795464-A | Co-particles of enzyme and bleach catalyst | 诺维信公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106661563-A | Oxidation-stable alpha-amylase variants | 诺维信公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106459944-A | Alpha-amylase variants | 诺维信公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-102947369-A | Organopolysiloxane and use thereof as surfactant, powder treatment agent, thickening agent of oil -based raw material or gelling agent. gel and emulsion compositions, as well as, preparations for external use and cosmetics comprising the same | DOW CORNING TORAY CO LTD | 2013-02-27 | — | — | CN | disclosed |
| CN-102906161-A | Novel organopolysiloxane, surfactant, emulsion composition, powder treatment agent, thickening agent of oil-based raw material, gelling agent, gel composition, and cosmetic raw material comprising novel organopolysiloxane, as well as, preparation for external use and cosmetic comprising the same | DOW CORNING TORAY CO LTD | 2013-01-30 | — | — | CN | disclosed |
| US-20130023591-A1 | Phenyl-Containing Organopolysiloxane Composition, Raw Cosmetic Material, and Glossy Cosmetic Material | DOW CORNING TORAY CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| CN-101874063-B | Methods for forming microporous and antimicrobial articles | 3M INNOVATIVE PROPERTIES CO | 2013-01-02 | — | — | CN | disclosed |
| EP-2519587-A1 | PHENYL-CONTAINING ORGANOPOLYSILOXANE COMPOSITION, RAW COSMETIC MATERIAL, AND GLOSSY COSMETIC MATERIAL | Dow Corning Toray Co., Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
| CN-102639542-A | Linear and cyclic siloxanes and cosmetic compositions made thereof | DOW CORNING TORAY CO LTD | 2012-08-15 | — | — | CN | disclosed |
| CN-102458385-A | Oral care method and kit | 3M INNOVATIVE PROPERTIES CO | 2012-05-16 | — | — | CN | disclosed |
| CN-102154667-A | Anti-displacement hard gold compositions | ROHM & HAAS ELECT MAT | 2011-08-17 | — | — | CN | disclosed |
| WO-2011081218-A1 | PHENYL-CONTAINING ORGANOPOLYSILOXANE COMPOSITION, RAW COSMETIC MATERIAL, AND GLOSSY COSMETIC MATERIAL | DOW CORNING TORAY CO., LTD. (JP) | 2011-07-07 | — | — | WO | disclosed |
| CN-101874063-A | Methods for forming microporous and antimicrobial articles | 3M INNOVATIVE PROPERTIES CO | 2010-10-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023591-A1 | Phenyl-Containing Organopolysiloxane Composition, Raw Cosmetic Material, and Glossy Cosmetic Material | MITF, XPA, FANCI | LSS 736/4885DNM1 4844/4885MEN1 1693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.